Seoul

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Kidney cancer1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 41 trial

Status

• Completed2 trials

Lead sponsor

• Eisai Korea Inc.2 trials

Closed trials

• Completed

  A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

  NCT06625242· Phase 4· Eisai Korea Inc.· Source

• Completed

  A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients

  NCT05375136· Eisai Korea Inc.· Source